Two Sigma Advisers’s Neurocrine Biosciences NBIX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-3,600
| Closed | -$398K | – | 2457 |
|
|
2025
Q1 | $398K | Buy |
+3,600
| New | +$398K | ﹤0.01% | 1878 |
|
|
2024
Q4 | – | Sell |
-3,873
| Closed | -$446K | – | 2459 |
|
|
2024
Q3 | $446K | Sell |
3,873
-30,900
| -89% | -$3.56M | ﹤0.01% | 1754 |
|
|
2024
Q2 | $4.79M | Sell |
34,773
-160,500
| -82% | -$22.1M | 0.01% | 774 |
|
|
2024
Q1 | $26.9M | Sell |
195,273
-15,200
| -7% | -$2.1M | 0.06% | 281 |
|
|
2023
Q4 | $27.7M | Sell |
210,473
-84,400
| -29% | -$11.1M | 0.06% | 267 |
|
|
2023
Q3 | $33.2M | Sell |
294,873
-259,400
| -47% | -$29.2M | 0.09% | 206 |
|
|
2023
Q2 | $52.3M | Sell |
554,273
-124,500
| -18% | -$11.7M | 0.13% | 168 |
|
|
2023
Q1 | $68.7M | Sell |
678,773
-43,900
| -6% | -$4.44M | 0.18% | 118 |
|
|
2022
Q4 | $86.3M | Buy |
722,673
+127,700
| +21% | +$15.3M | 0.24% | 92 |
|
|
2022
Q3 | $63.2M | Buy |
594,973
+130,100
| +28% | +$13.8M | 0.18% | 137 |
|
|
2022
Q2 | $45.3M | Sell |
464,873
-163,900
| -26% | -$16M | 0.13% | 171 |
|
|
2022
Q1 | $58.9M | Buy |
628,773
+435,600
| +225% | +$40.8M | 0.16% | 139 |
|
|
2021
Q4 | $16.5M | Buy |
193,173
+176,300
| +1,045% | +$15M | 0.04% | 352 |
|
|
2021
Q3 | $1.62M | Buy |
+16,873
| New | +$1.62M | ﹤0.01% | 1369 |
|
|
2020
Q4 | – | Sell |
-430,299
| Closed | -$41.4M | – | 2517 |
|
|
2020
Q3 | $41.4M | Sell |
430,299
-297,874
| -41% | -$28.6M | 0.12% | 174 |
|
|
2020
Q2 | $88.8M | Buy |
728,173
+9,500
| +1% | +$1.16M | 0.26% | 85 |
|
|
2020
Q1 | $62.2M | Sell |
718,673
-112,500
| -14% | -$9.74M | 0.24% | 100 |
|
|
2019
Q4 | $89.3M | Buy |
831,173
+98,200
| +13% | +$10.6M | 0.21% | 114 |
|
|
2019
Q3 | $66M | Sell |
732,973
-66,300
| -8% | -$5.97M | 0.16% | 152 |
|
|
2019
Q2 | $67.5M | Buy |
799,273
+42,400
| +6% | +$3.58M | 0.17% | 158 |
|
|
2019
Q1 | $66.7M | Buy |
756,873
+134,400
| +22% | +$11.8M | 0.17% | 159 |
|
|
2018
Q4 | $44.5M | Buy |
622,473
+77,000
| +14% | +$5.5M | 0.12% | 217 |
|
|
2018
Q3 | $67.1M | Buy |
545,473
+238,400
| +78% | +$29.3M | 0.16% | 169 |
|
|
2018
Q2 | $30.2M | Buy |
307,073
+277,400
| +935% | +$27.3M | 0.08% | 306 |
|
|
2018
Q1 | $2.46M | Buy |
29,673
+18,561
| +167% | +$1.54M | 0.01% | 1152 |
|
|
2017
Q4 | $862K | Buy |
+11,112
| New | +$862K | ﹤0.01% | 1573 |
|
|
2017
Q3 | – | Sell |
-11,600
| Closed | -$534K | – | 2303 |
|
|
2017
Q2 | $534K | Sell |
11,600
-6,900
| -37% | -$318K | ﹤0.01% | 1772 |
|
|
2017
Q1 | $801K | Hold |
18,500
| – | – | ﹤0.01% | 1687 |
|
|
2016
Q4 | $716K | Buy |
18,500
+11,327
| +158% | +$438K | ﹤0.01% | 1699 |
|
|
2016
Q3 | $363K | Buy |
+7,173
| New | +$363K | ﹤0.01% | 1815 |
|
|
2016
Q2 | – | Sell |
-39,973
| Closed | -$1.58M | – | 2145 |
|
|
2016
Q1 | $1.58M | Buy |
39,973
+10,400
| +35% | +$411K | 0.01% | 905 |
|
|
2015
Q4 | $1.67M | Sell |
29,573
-37,500
| -56% | -$2.12M | 0.01% | 808 |
|
|
2015
Q3 | $2.68M | Buy |
67,073
+48,500
| +261% | +$1.94M | 0.02% | 653 |
|
|
2015
Q2 | $887K | Buy |
18,573
+2,600
| +16% | +$124K | 0.01% | 1172 |
|
|
2015
Q1 | $634K | Buy |
+15,973
| New | +$634K | ﹤0.01% | 1253 |
|
|
2014
Q4 | – | Sell |
-17,573
| Closed | -$275K | – | 2195 |
|
|
2014
Q3 | $275K | Buy |
+17,573
| New | +$275K | ﹤0.01% | 1472 |
|
|
2014
Q1 | – | Sell |
-18,173
| Closed | -$170K | – | 1895 |
|
|
2013
Q4 | $170K | Buy |
+18,173
| New | +$170K | ﹤0.01% | 1656 |
|
|
2013
Q3 | – | Sell |
-14,137
| Closed | -$189K | – | 1738 |
|
|
2013
Q2 | $189K | Buy |
+14,137
| New | +$189K | ﹤0.01% | 1426 |
|